Position in BCRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$429,550
+$20,619 QoQ
Shares Held
42,955
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Fiduciary Trust Co holds $3,825,180 across 6 Drug Manufacturers - Specialty & Generic names. BCRX ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
23,564 | $1,693,308 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
14,695 | $683,464 | |
| 3 | HLN |
Haleon plc
|
60,765 | $566,936 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
42,955 | $429,550 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,005 | $337,922 | |
| 6 | AKBA |
Akebia Therapeutics, Inc.
|
100,000 | $114,000 |
All Filings in BCRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $429,550 | 42,955 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $408,931 | 42,955 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $290,573 | 37,253 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $197,484 | 26,019 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $233,130 | 26,019 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $195,142 | 26,019 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||